EVOLUS INC (EOLS) Fundamental Analysis & Valuation

NASDAQ:EOLS • US30052C1071

Current stock price

4.33 USD
+0.06 (+1.41%)
At close:
4.33 USD
0 (0%)
After Hours:

This EOLS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EOLS Profitability Analysis

1.1 Basic Checks

  • EOLS had negative earnings in the past year.
  • EOLS had a negative operating cash flow in the past year.
  • In the past 5 years EOLS always reported negative net income.
  • In the past 5 years EOLS always reported negative operating cash flow.
EOLS Yearly Net Income VS EBIT VS OCF VS FCFEOLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

  • EOLS has a Return On Assets (-22.86%) which is in line with its industry peers.
Industry RankSector Rank
ROA -22.86%
ROE N/A
ROIC N/A
ROA(3y)-25.73%
ROA(5y)-27.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EOLS Yearly ROA, ROE, ROICEOLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600 -800

1.3 Margins

  • EOLS's Gross Margin of 66.33% is fine compared to the rest of the industry. EOLS outperforms 73.30% of its industry peers.
  • EOLS's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for EOLS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.06%
GM growth 5Y-0.38%
EOLS Yearly Profit, Operating, Gross MarginsEOLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. EOLS Health Analysis

2.1 Basic Checks

  • EOLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for EOLS has been increased compared to 1 year ago.
  • EOLS has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EOLS is higher compared to a year ago.
EOLS Yearly Shares OutstandingEOLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EOLS Yearly Total Debt VS Total AssetsEOLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • EOLS has an Altman-Z score of -2.30. This is a bad value and indicates that EOLS is not financially healthy and even has some risk of bankruptcy.
  • EOLS has a Altman-Z score of -2.30. This is comparable to the rest of the industry: EOLS outperforms 41.36% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.3
ROIC/WACCN/A
WACC10.42%
EOLS Yearly LT Debt VS Equity VS FCFEOLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

2.3 Liquidity

  • EOLS has a Current Ratio of 1.90. This is a normal value and indicates that EOLS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of EOLS (1.90) is worse than 65.44% of its industry peers.
  • EOLS has a Quick Ratio of 1.54. This is a normal value and indicates that EOLS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.54, EOLS is doing worse than 65.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.54
EOLS Yearly Current Assets VS Current LiabilitesEOLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. EOLS Growth Analysis

3.1 Past

  • The earnings per share for EOLS have decreased strongly by -72.00% in the last year.
  • Looking at the last year, EOLS shows a quite strong growth in Revenue. The Revenue has grown by 11.61% in the last year.
  • The Revenue has been growing by 39.38% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y25.99%
Revenue growth 5Y39.38%
Sales Q2Q%13.01%

3.2 Future

  • Based on estimates for the next years, EOLS will show a very strong growth in Earnings Per Share. The EPS will grow by 49.20% on average per year.
  • The Revenue is expected to grow by 16.65% on average over the next years. This is quite good.
EPS Next Y69.16%
EPS Next 2Y58.62%
EPS Next 3Y52.69%
EPS Next 5Y49.2%
Revenue Next Year11.32%
Revenue Next 2Y14.42%
Revenue Next 3Y15.7%
Revenue Next 5Y16.65%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EOLS Yearly Revenue VS EstimatesEOLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
EOLS Yearly EPS VS EstimatesEOLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

1

4. EOLS Valuation Analysis

4.1 Price/Earnings Ratio

  • EOLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year EOLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EOLS Price Earnings VS Forward Price EarningsEOLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EOLS Per share dataEOLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

  • EOLS's earnings are expected to grow with 52.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.62%
EPS Next 3Y52.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EOLS Dividend Analysis

5.1 Amount

  • No dividends for EOLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EOLS Fundamentals: All Metrics, Ratios and Statistics

EVOLUS INC

NASDAQ:EOLS (4/13/2026, 8:23:01 PM)

After market: 4.33 0 (0%)

4.33

+0.06 (+1.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-03
Earnings (Next)05-05
Inst Owners71.69%
Inst Owner Change-0.01%
Ins Owners11.95%
Ins Owner Change6.27%
Market Cap281.71M
Revenue(TTM)297.18M
Net Income(TTM)-51.64M
Analysts84.62
Price Target14.96 (245.5%)
Short Float %14.72%
Short Ratio6.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.56%
Min EPS beat(2)17.65%
Max EPS beat(2)37.48%
EPS beat(4)2
Avg EPS beat(4)-13.65%
Min EPS beat(4)-108.79%
Max EPS beat(4)37.48%
EPS beat(8)5
Avg EPS beat(8)-8.97%
EPS beat(12)8
Avg EPS beat(12)-11.04%
EPS beat(16)11
Avg EPS beat(16)-6.47%
Revenue beat(2)1
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)0.25%
Revenue beat(4)1
Avg Revenue beat(4)-6.56%
Min Revenue beat(4)-17.08%
Max Revenue beat(4)0.25%
Revenue beat(8)2
Avg Revenue beat(8)-3.79%
Revenue beat(12)5
Avg Revenue beat(12)-1.71%
Revenue beat(16)6
Avg Revenue beat(16)-1.41%
PT rev (1m)0%
PT rev (3m)-20.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-77.28%
EPS NY rev (1m)-254.51%
EPS NY rev (3m)-177.38%
Revenue NQ rev (1m)-0.78%
Revenue NQ rev (3m)-9.64%
Revenue NY rev (1m)-0.99%
Revenue NY rev (3m)-9.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.95
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.78
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS4.57
BVpS-0.36
TBVpS-1.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22.86%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.33%
FCFM N/A
ROA(3y)-25.73%
ROA(5y)-27.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.06%
GM growth 5Y-0.38%
F-Score2
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 112.6%
Cap/Sales 2.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 1.54
Altman-Z -2.3
F-Score2
WACC10.42%
ROIC/WACCN/A
Cap/Depr(3y)78.45%
Cap/Depr(5y)66.33%
Cap/Sales(3y)1.82%
Cap/Sales(5y)1.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y69.16%
EPS Next 2Y58.62%
EPS Next 3Y52.69%
EPS Next 5Y49.2%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y25.99%
Revenue growth 5Y39.38%
Sales Q2Q%13.01%
Revenue Next Year11.32%
Revenue Next 2Y14.42%
Revenue Next 3Y15.7%
Revenue Next 5Y16.65%
EBIT growth 1Y-38.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year305.01%
EBIT Next 3Y118.29%
EBIT Next 5Y103.85%
FCF growth 1Y-122.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-134.82%
OCF growth 3YN/A
OCF growth 5YN/A

EVOLUS INC / EOLS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EVOLUS INC (EOLS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to EOLS.


What is the valuation status of EVOLUS INC (EOLS) stock?

ChartMill assigns a valuation rating of 1 / 10 to EVOLUS INC (EOLS). This can be considered as Overvalued.


What is the profitability of EOLS stock?

EVOLUS INC (EOLS) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for EOLS stock?

The Earnings per Share (EPS) of EVOLUS INC (EOLS) is expected to grow by 69.16% in the next year.